La tecnología que aprende a elegir tu talla de calzado

Ballester Fernandez, A.; Gil Mora, S.; Valero, J.; Gonzalez Garcia, JC.; Remon Gomez, A. (2019). La tecnología que aprende a elegir tu talla de calzado. Innovación biomecánica en Europa. (8):1-3. http://hdl.handle.net/10251/167979S13

Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial

Background: Polyphenols may lower the risk of cardiovascular disease (CVD) and other chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their beneficial effects on blood pressure, lipids and insulin resistance. However, no previous epidemiological studies have evaluated the relationship between the intake of total polyphenols intake and polyphenol subclasses with overall mortality. Our aim was to evaluate whether polyphenol intake is associated with all-cause mortality in subjects at high cardiovascular risk. Methods: We used data from the PREDIMED study, a 7,447-participant, parallel-group, randomized, multicenter, controlled five-year feeding trial aimed at assessing the effects of the Mediterranean Diet in primary prevention of cardiovascular disease. Polyphenol intake was calculated by matching food consumption data from repeated food frequency questionnaires (FFQ) with the Phenol-Explorer database on the polyphenol content of each reported food. Hazard ratios (HR) and 95% confidence intervals (CI) between polyphenol intake and mortality were estimated using time-dependent Cox proportional hazard models. Results: Over an average of 4.8 years of follow-up, we observed 327 deaths. After multivariate adjustment, we found a 37% relative reduction in all-cause mortality comparing the highest versus the lowest quintiles of total polyphenol intake (hazard ratio (HR) = 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among the polyphenol subclasses, stilbenes and lignans were significantly associated with reduced all-cause mortality (HR =0.48; 95% CI 0.25 to 0.91; P for trend = 0.04 and HR = 0.60; 95% CI 0.37 to 0.97; P for trend = 0.03, respectively), with no significant associations apparent in the rest (flavonoids or phenolic acids). Conclusions: Among high-risk subjects, those who reported a high polyphenol intake, especially of stilbenes and lignans, showed a reduced risk of overall mortality compared to those with lower intakes. These results may be useful to determine optimal polyphenol intake or specific food sources of polyphenols that may reduce the risk of all-cause mortality. Clinical trial registration: ISRCTN35739639

MOVE 4D: el IBV desarrolla el sistema más avanzado de escaneado del cuerpo humano en movimiento

[ES] El Instituto de Biomecánica (IBV) se sitúa en la vanguardia de la tecnología digital de caracterización antropométrica y biomecánica del cuerpo humano, mediante el desarrollo del equipo MOVE 4D, un sistema de escaneado corporal en movimiento de alta precisión y velocidad. Con este sistema se abren nuevas opciones de avance y desarrollo en sectores tan variados como la indumentaria-textil, la valoración biomecánica en salud y deporte, la animación digital o los vídeo-juegos.El trabajo actual se ha desarrollado en el marco del proyecto 3D-body-dynamics financiado por el IVACE dentro del programa de subvenciones dirigidas a los centros tecnológicos de Comunidad Valenciana para el desarrollo de proyectos de I+D no económicos. Está cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) en un porcentaje del 50% a través del programa operativo FEDER de la Comunidad Valenciana 2014-2020. La colaboración con el IBV del investigador Dr. Alfredo Remón está cofinanciada por el programa Torres Quevedo (Ref. PTQ -16- 08205)Alemany Mut, MS.; Garrido Jaen, JD.; Parrilla Bernabé, E.; Mañas Ballester, B.; Remon Gomez, A. (2019). MOVE 4D: el IBV desarrolla el sistema más avanzado de escaneado del cuerpo humano en movimiento. Revista de Biomecánica (Online). (66):1-4. http://hdl.handle.net/10251/159754S146

3D-body-hub: Herramientas para incorporar la antropometría en el diseño de producto

Solves Camallonga, C.; Gil Mora, S.; Nacher Fernandez, B.; Uriel-Molto, J.; Ballester Fernandez, A.; Alemany Mut, MS.; Remon Gomez, A.... (2019). 3D-body-hub: Herramientas para incorporar la antropometría en el diseño de producto. Innovación biomecánica en Europa. (8):1-9. http://hdl.handle.net/10251/169346S19

Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial

Background: Polyphenols may lower the risk of cardiovascular disease (CVD) and other chronic diseases due to their antioxidant and anti-inflammatory properties, as well as their beneficial effects on blood pressure, lipids and insulin resistance. However, no previous epidemiological studies have evaluated the relationship between the intake of total polyphenols intake and polyphenol subclasses with overall mortality. Our aim was to evaluate whether polyphenol intake is associated with all-cause mortality in subjects at high cardiovascular risk. Methods: We used data from the PREDIMED study, a 7,447-participant, parallel-group, randomized, multicenter, controlled five-year feeding trial aimed at assessing the effects of the Mediterranean Diet in primary prevention of cardiovascular disease. Polyphenol intake was calculated by matching food consumption data from repeated food frequency questionnaires (FFQ) with the Phenol-Explorer database on the polyphenol content of each reported food. Hazard ratios (HR) and 95% confidence intervals (CI) between polyphenol intake and mortality were estimated using time-dependent Cox proportional hazard models. Results: Over an average of 4.8 years of follow-up, we observed 327 deaths. After multivariate adjustment, we found a 37% relative reduction in all-cause mortality comparing the highest versus the lowest quintiles of total polyphenol intake (hazard ratio (HR) = 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among the polyphenol subclasses, stilbenes and lignans were significantly associated with reduced all-cause mortality (HR =0.48; 95% CI 0.25 to 0.91; P for trend = 0.04 and HR = 0.60; 95% CI 0.37 to 0.97; P for trend = 0.03, respectively), with no significant associations apparent in the rest (flavonoids or phenolic acids). Conclusions: Among high-risk subjects, those who reported a high polyphenol intake, especially of stilbenes and lignans, showed a reduced risk of overall mortality compared to those with lower intakes. These results may be useful to determine optimal polyphenol intake or specific food sources of polyphenols that may reduce the risk of all-cause mortality. Clinical trial registration: ISRCTN35739639